Sunday, September 20, 2026

Aggressive Portfolio Trades: Buy Vail Resorts, Buy ORR, Short GEO

Vail Resorts, down 60% since 2022, is pitched for an El Niño-driven ski-season rebound; the portfolio also buys ORR and shorts GEO.

MTN $4.9BGEO $4.1B

Ian’s Insider Corner Sep 20 7 clicks

Sep 20 WEN $1.3B

🍔New Chapter 11 Bankruptcy Filing - Meritage Hospitality Group Inc.🍔

PETITION 1 click

Sep 20 BN $82B

Deep Dive: Brookfield Corporation

Capitalist Letters 2 clicks

From X

@DeepSailCapital Sep 20 1 click

Deep Sail Capital on X

@marketplunger1 A majority of them are in Japan or Korea $OUST - LiDAR leader. $NOVT - Drives, motion, medical. M&A strategy in robotics end market. It’s really expensive though.

@marginofdanger Sep 20 2 clicks

marginofdanger on X

Fundamental issue with $HHH is there is no return of capital to shareholders and no consistent base of earnings either. I strongly preferred the company as a real estate only situation. He massively overpaid for Vantage too. Will trade cheap to NAV until it’s truly shareholder friendly.

@BillAckman Sep 20 2 clicks

Bill Ackman on X

An excellent and insightful report on $HHH. https://t.co/cvFpfHoAkP

@BarbarianCap Sep 20

Barbarian Capital on X

Chevron plans drilling spree as it overhauls oil and gas search $CVX https://t.co/aZV7kguxYR

@TidefallCapital Sep 20

Trevor Scott on X

@optionscjp $NFLX has historically auto cancelled inactive accounts

@TidefallCapital Sep 20 1 click

Trevor Scott on X

@TheRayMyers why not $MU at 6.5x?

@irbezek Sep 20 2 clicks

Ian Bezek on X

@Tintincapital @valuehurts Has already happened, no? The $WING and $CAVA style restaurant growth stories have collapsed. Or look at something like Vail Resorts, down 65% off the 2022 peak.

@BarbarianCap Sep 20 1 click

Barbarian Capital on X

Hot Honey no, thanks good buzz for $HRL tho https://t.co/ythkEhbNVK

Investor Letters

All letters

Berkshire Hathaway: Warren Buffett Steps Down As Chairman While Higher Rates Turn The Cash Pile Into A Bigger Asset

Berkshire Hathaway's $324.9 billion T-bill portfolio benefits from higher rates as Greg Abel succeeds Warren Buffett and BHE adds 11,000 MW…

BRK.A $1.1T

Steven Fiorillo Sep 20

Palo Alto Networks (NASDAQ: PANW) Stock Rating: Do Nothing After Q4 FY7/26 Earnings

Palo Alto Networks posted 34% Q4 revenue growth to $3.41 billion, boosted by CyberArk and Chronosphere, while NGS ARR reached $9.1 billion…

PANW $322B

Cestrian Capital Research. Sep 19 1 click

Pacific Health Care Organization - OTC:PFHO

Pacific Health Care trades below its more than $1 per-share net cash despite profitable workers’ compensation claims services, California…

PFHO $13M

Obscure Stocks Sep 19 3 clicks

Thoughts on GFL’s Take Private - Is Dovigi Indifferent?

GFL’s take-private process has drawn KKR, Blackstone, Brookfield and IFM, while CEO Patrick Dovigi signals he will accept only the right…

GFL $15B

310 Value’s Newsletter Sep 19 2 clicks

Brookfield of Dreams

Brookfield is recasting itself from an industrial owner into a $1.3 trillion asset manager and insurer, betting AI infrastructure can…

BN $82B

Net Interest Sep 19

Karman: Why I'm Upgrading To Buy After A 68% Drop

Karman Holdings (KRMN) is upgraded after a 68% drop, with 24% organic growth, a $1.3 billion backlog and higher 2026 guidance offset by…

KRMN $4.4B

Dhierin Bechai Sep 19 1 click

Why Dario Amodei and Sam Altman Are Faking the AI Doomsday Crisis | The Weekly Wrap

Steve Eisman argues AI extinction warnings from Dario Amodei and Sam Altman seek regulation that creates pricing moats.

FICO $19B

Steve Eisman Sep 18 2 clicks

$NTDOY: is Nintendo's flywheel actually there? | Accrued Interest

Nintendo's Switch 2 attach rate, flat Switch Online accounts and rising memory costs fuel a bear case, while Spotify and Netflix margins…

NTDOY $57B

Yet Another Value Podcast Sep 18 1 click

Groceries, Aggregators, and Agents

DoorDash's grocery push targets a shift from weekly stock-up trips to frequent online fill-in orders, though smaller baskets complicate…

DASH $81B

MBI Deep Dives Sep 18 1 click

Planet's Next Constellation Is Bigger Than Just An Upgrade

Planet Labs’ $116.1 million second-quarter revenue, 70% defense mix and planned Owl constellation position satellite imagery and AI data as…

PL $6B

Petri Dish Reports Sep 18 2 clicks

MHEYF · long

Maha Capital

Maha Capital combines two assets valued at least 2x its pro forma market capitalization, with a catalyst intended to close the discount.

MHEYF $271M

Value Investors Club May 3 3 clicks

(C)riminally (V)alued (S)caled Healthcare Services

CVS Health fell 20% after cutting 2024 adjusted EPS guidance to $7, but its Aetna insurance and Caremark PBM businesses support a…

CVS $113B

Rod’s Ruminations May 1

A 4x in 4 Years Surfing the Data Center Tsunami? ($TSSI)

Total Site Solutions ($TSSI) depends on Dell for 96% of revenue; the 4x thesis rests on Dell expanding modular data centers amid AI-driven…

TSSI $288M

Multibagger Monitor Apr 16 4 clicks

~9 EV/OCF AI Company Growing Revenue 75%+ YoY ($ALAR)

Alarum ($ALAR) trades near 9x operating cash flow as its NetNut proxy network supports web scraping and AI data collection, with revenue…

ALAR $15M

Multibagger Monitor Mar 24 1 click

A Mexican Blue Chip Bargain

Grupo Herdez, a MXN 15.2 billion Mexican food company, pairs dominant grocery brands with McCormick, Barilla and Hormel joint ventures.

GUZOF $1B

Exploring with Alluvial Capital Mar 7

Nvidia, Nano-X and the interpretation of 13F filings

Nvidia’s $380,000 Nano-X stake came from Zebra Medical Vision’s acquisition and is managed by another reporting person, undermining the 50%…

NNOX $69M

John Hempton's Newsletter Feb 15 2 clicks

Checking Out Music Royalties

Mills Music Trust's 8.5% yield faces declining distributions as songs enter the public domain, while Royalty Exchange lists more than 700…

MMTRS

Exploring with Alluvial Capital Feb 1

Quality Investing Outside the Blue Chips

Rand Worldwide, an Autodesk reseller, grew revenue from $116 million to $306 million while using less equity; expired three-year…

RWWI $320M

Exploring with Alluvial Capital Dec 26

Sarepta Risk and the FDA

Sarepta’s Exondys 51 approval despite a 12-patient trial frames FDA regulatory risk and a call to remove Commissioner Robert Califf.

SRPT $2.2B

John Hempton's Newsletter Oct 31 1 click

Does anyone remember when Alnylam went up 50 percent in a day on a phase three result

Alnylam’s 2022 50% phase-three gain faces FDA advisory-panel scrutiny over its amyloidosis drug’s label extension.

ALNY $33B

John Hempton's Newsletter Sep 12

Sunday, September 20, 2026

Deep Sail Capital on X

marginofdanger on X

Bill Ackman on X

Barbarian Capital on X

Trevor Scott on X

Trevor Scott on X

Ian Bezek on X

Barbarian Capital on X

Investor Letters

Publications we follow

Newsletters 91

YouTube 4

Blogs 12

Seeking Alpha 31 of 175

X accounts we follow

Investor letters we follow

Sectors